Acute Myocarditis Related to COVID-19: Comparison to SARS and MERS
Abstract Myocardial involvement has been described during previous SARS and MERS outbreaks. Infection by SARS-CoV-2 (COVID-19) can range from asymptomatic to life-threatening multi-system disease. Heart involvement most commonly occurs during severe COVID-19 infection. Myocardial injury, based on elevated levels of myocardial enzymes, has been noted in up to 30% of patients with COVID-19 infection and could be a marker for worse prognosis. A few cases of possible myocarditis due to SARS-CoV-2 have been described, providing variable degree of evidence of direct myocardial involvement. We reviewed in detail those cases in comparison to relevant literature on SARS and MERS and attempted to draw initial conclusions in regard to clinical presentation, treatment and prognosis..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
SN comprehensive clinical medicine - 2(2020), 12 vom: 20. Nov., Seite 2684-2690 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chasouraki, Angeliki M. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.1007/s42399-020-00563-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR042310873 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR042310873 | ||
| 003 | DE-627 | ||
| 005 | 20230520004909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201210s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s42399-020-00563-y |2 doi | |
| 035 | |a (DE-627)SPR042310873 | ||
| 035 | |a (DE-599)SPRs42399-020-00563-y-e | ||
| 035 | |a (SPR)s42399-020-00563-y-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Chasouraki, Angeliki M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acute Myocarditis Related to COVID-19: Comparison to SARS and MERS |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Myocardial involvement has been described during previous SARS and MERS outbreaks. Infection by SARS-CoV-2 (COVID-19) can range from asymptomatic to life-threatening multi-system disease. Heart involvement most commonly occurs during severe COVID-19 infection. Myocardial injury, based on elevated levels of myocardial enzymes, has been noted in up to 30% of patients with COVID-19 infection and could be a marker for worse prognosis. A few cases of possible myocarditis due to SARS-CoV-2 have been described, providing variable degree of evidence of direct myocardial involvement. We reviewed in detail those cases in comparison to relevant literature on SARS and MERS and attempted to draw initial conclusions in regard to clinical presentation, treatment and prognosis. | ||
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Myocarditis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Myocardial injury |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Troponin |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Corticosteroids |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Treatment |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Violetis, Odyssefs A. |e verfasserin |4 aut | |
| 700 | 1 | |a Abdelrasoul, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Tsagalou, Eleftheria P. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d [Cham] : Springer International Publishing, 2019 |g 2(2020), 12 vom: 20. Nov., Seite 2684-2690 |w (DE-627)SPR038535785 |w (DE-600)2947252-0 |x 2523-8973 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2020 |g number:12 |g day:20 |g month:11 |g pages:2684-2690 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s42399-020-00563-y |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2020 |e 12 |b 20 |c 11 |h 2684-2690 | ||